Microbiology Studies of Acute Head and Neck Infections
Identifying the Microorganisms Responsible for Acute Head and Neck Infections.
1 other identifier
observational
150
1 country
1
Brief Summary
Acute head and neck infections cause significant pain and discomfort for patients and impact on their quality of life. Effective antibiotic and surgical treatments have been developed for these infections but they are still able to develop into life-threatening diseases such as meningitis and sepsis. The direct cause of acute head and neck infections is often unknown but it has been suggested that they are due to a disturbance of the normal bacterial growing in the mouth or are from dental origin. The most common microorganisms identified from these infections in published studies are a group of bacteria known as viridans group streptococci (VGS). There are over 30 individual species of bacteria in the viridans group and VGS are difficult to identify to the level of a single species because of their variability. There is a lack of species identification within the hospital setting and this project aims to gain a deeper understanding of the microorganisms causing acute head and neck infections, focusing on identification of individual species of VGS bacteria. The investigators will analyse bacterial DNA to determine which species have been identified and will also look at patient data and clinical outcomes (eg. length of hospital stay) to determine if the species causing the infection has any effect on patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2023
CompletedFirst Posted
Study publicly available on registry
May 25, 2023
CompletedStudy Start
First participant enrolled
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2026
CompletedFebruary 28, 2025
February 1, 2025
1.1 years
May 8, 2023
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of Streptococci Species
Identification by DNA analysis of ribosomal ribonucleic acid (rRNA) genes and biochemical testing.
4 years
Secondary Outcomes (6)
Patient Characteristics
4 Years
Patient Characteristics
4 Years
Patient Characteristics
4 Years
Clinical Outcomes
4 Years
Clinical Outcomes
4 Years
- +1 more secondary outcomes
Eligibility Criteria
Patients diagnosed with acute head and neck infections at Northampton General Hospital.
You may qualify if:
- Over the age of 18
- Suffering with acute head and neck infection of Streptococci.
- Samples must come from Northampton General Hospital.
- Consent to participate in research with at least 24 hours of consideration.
You may not qualify if:
- Age \<18 years.
- Samples from other National Health Service (NHS) hospitals.
- Infections from other areas of the body.
- Infection identified as caused by non-streptococcal bacteria.
- Chosen not to participate in research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Northampton
Northampton, NN1 5PH, United Kingdom
Related Links
Biospecimen
Bacterial isolates from pus swabs.
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Woodacre, PhD, BSc
University of Northampton
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 8, 2023
First Posted
May 25, 2023
Study Start
March 3, 2025
Primary Completion
April 19, 2026
Study Completion
April 19, 2026
Last Updated
February 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- October 2025
Only share pseudonymised data of participant/clinical outcomes.